Breaking News

Craig Gibbs
About Craig Gibbs
SUMMARY OF EXPERIENCE
• Ph.D. (Molecular Biology) and M.B.A.
• 31 years of industry experience including 24 years at Genentech and Gilead
• Leadership roles spanning Research & Development, Corporate Development and Commercial
• Therapeutic area knowledge in Infectious Diseases, Liver, Cardiovascular, Respiratory, Inflammation, Oncology
• Scientific expertise in Biochemistry, Molecular Biology, Protein Engineering, Protein Kinases, Blood Coagulation, Virology, Prodrug Pharmacology, Drug Discovery, Drug Development
• >50 scientific publications, 3 issued patents
• Contributed to 10 NDAs, and commercial preparation for 5 product launches
• Participated in 9 corporate acquisitions, 11 in-licensing and 2 out-licensing transactions
• Contributed to raising a combined $361M in Series B, IPO and secondary public financings
• Contributed to the $4.9B acquisition of Forty Seven by Gilead